These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-001919-21 Phase II-Studie: Standardchemotherapie Capecitabin in Kombination mit Bevacizumab in der Erstlinientherapie beim metastasierten kolorektalen Karzinom 2010-03-03 due-trials
Exempt 2005-003327-39 Integration of 3D-conformal, local radiotherapy (3DCRT) to metastatic sites in a paclitaxel weekly chemotherapy regimen in oligometastatic breast cancer patients: a phase I- and randomised phase II-st... not-yet-due
Exempt Terminated 2005-003910-13 Phase I/II Studie zum Einsatz von Capecitabin und Oxaliplatin (XELOX) in Kombination mit Cetuximab und Bevacizumab in der Erstlinientherapie von Patienten mit fortgeschrittenem kolorektalem Karzinom 2008-06-05 not-yet-due
Listed as ongoing, but also has a completion date 2006-000995-33 EuroNet-Paediatric Hodgkin’s Lymphoma Group 2018-10-30 bad-data
Not reported 2006-004504-39 Multizentrische Phase II-Studie mit Docetaxel, Oxaliplatin und Capecitabin (TEX) bei Patienten mit inoperablem oder metastasiertem Magenkarzinom 2012-12-20 due-trials
Not reported 2006-006004-11 Phase II – Studie P-ICE Hochdosischemotherapie mit Paclitaxel, Ifosfamid,Carboplatin und Etoposid mit autologem Stammzellsupport bei männlichen Patienten mit refraktären oder rezidivierten Keimzelltum... 2018-07-31 due-trials
Not reported 2007-000128-42 International cooperative Phase II trial of the HIT-HGG study group for the treatment of high grade glioma, diffuse intrinsic pontine glioma, and gliomatosis cerebri in children ≥ 3 years and adolesce... 2019-06-30 due-trials
Not reported Terminated 2007-002384-27 Hyperbarer Sauerstoff (HBO) in der Behandlung der radiogenen Xerostomie - Eine randomisierte, prospektive Multizenter-Studie 2011-03-24 due-trials
Not reported Terminated 2007-003003-12 Die Bedeutung der Inflammationslast („inflammatory/pathogen burden“) für das kardiale Altern 2014-07-21 due-trials
Other 2007-004092-19 EuroNet-Paediatric Hodgkin’s Lymphoma Group not-yet-due
Not reported Terminated 2007-005679-33 Influence of the selective endothelin receptor-blocker Ambrisetan on the portal pressure in patients with cirrhosis 2016-12-12 due-trials
Ongoing 2007-006087-30 Prospektive randomisierte klinische Studie zur Beurteilung der Effizienz und Sicherheit einer inhalativen Sedierung mit Sevofluran im Vergleich zu einem intravenösen Sedierungskonzept mit Propofol bei... not-yet-due
Ongoing 2009-011898-33 Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents - A Phase II Study not-yet-due
Completed, but no date Terminated 2009-011904-47 Sorafenib plus doxorubicin versus sorafenib alone for the treatment of advanced hepatocellular carcinoma: a randomized phase II trial bad-data
Not reported 2009-012088-32 Prospektive und randomisierte Multicenter-Studie (Phase III-Studie) zur Verbesserung der Funktion des Nervus facialis und des Nervus vestibulocochlearis nach der Resektion von Akustikusneurinomen durc... 2012-12-19 due-trials
Other 2009-014728-44 A randomized phase II trial of irinotecan drug-eluting beads administered by hepatic chemoembolization with intravenous cetuximab (DEBIRITUX) versus systemic treatment with intravenous cetuximab and i... not-yet-due
Not reported 2009-015499-88 Senkung einer erhöhten Herzfrequenz durch Ivabradin bei Patienten mit Multiorgandysfunktionssyndrom. 2012-11-05 due-trials
Not reported 2009-017261-32 Phase II randomized clinical trial of Pazopanib alone and Pazopanib plus Gemcitabine in relapsed or metastatic soft tissue sarcoma 2016-05-10 due-trials
Completed, but no date Terminated 2010-018665-30 COMFORT-study Comparison of Olanzapin and Metoclopramide For treatment Of bReakThrough emesis bad-data
Not reported 2010-022162-27 FOLFOX/bevacizumab with or without irinotecan in first-line treatment for metastatic colorectal cancer. A randomized phase II study. 2018-08-31 due-trials
Ongoing 2010-023050-37 A multicenter, randomized, phase II trial: BIBF 1120 vs. placebo in patients receiving oxaliplatin plus fluorouracil and leucovorin (mFOLFOX6) for advanced, chemorefractory metastatic colorectal cance... not-yet-due
Not reported 2012-000391-42 Investigation on the peritoneal tissue concentrations of antibiotics in surgical patients with peritonitis using microdialysis. Example: linezolide, tigecycline 2016-12-31 due-trials
Exempt 2012-002154-23 Phase I/II pilot trial of ATRA (Tretinoin) and TCP (Tranylcypromine) in patients with relapsed or refractory acute myeloid leukemia (AML) when no intensive treatment is possible 2017-07-29 not-yet-due
Other 2012-004053-88 EuroNet-Paediatric Hodgkin’s Lymphoma Group not-yet-due
Other 2014-002702-21 A double- blind, placebo controlled, randomized, multicenter, Phase II study to assess the efficacy of BL-8040 addition to consolidation therapy in AML patients not-yet-due
Other 2015-002602-36 Efficacy and safety of high dose glucocorticosteroid treatment for idiopathic sudden sensorineural hearing loss (HODOKORT) not-yet-due
Ongoing 2017-001207-68 A multicenter single-arm pilot study of ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors not-yet-due
Ongoing 2019-001725-27 A randomized, open, three-arm comparative study of modern methods of postoperative pain therapy in patients with knee endoprostheses. not-yet-due
Ongoing 2019-003100-13 Pharmacokinetics of edoxaban in patients with advanced chronic kidney disease (CKD) treated for stroke prevention not-yet-due